Psoriatic Diseases and Obesity: Advancing Evidence on Inflammatory Synergies and Novel Treatment Strategies forImproved Patient Outcomes

October 24, 2026

Obesity is reshaping the clinical landscape of psoriatic disease (PsD), driving higher inflammatory and disease burden,accelerating comorbidities, and complicating treatment decisions and outcomes. While emerging GLP-1/GIP-based therapies are poised to transform obesity management, rheumatology clinicians face limited specialty-specific guidanceand a rapidly evolving evidence base. This activity - a 1.5-hour live webinar embedded in AWIR's Virtual Summit (October 24,2026), paired with a 1-year enduring webcast hosted on myCME - delivers rheumatology-specific education on theinflammatory synergies between obesity and PsD, emerging GLP-1/GIP therapies, and evidence-based patient selection andtreatment integration strategies. Delivered through AWIR's chapter network (60+ local chapters across the US) andmyCME's distribution platform, and evaluated via pre/post surveys and live polling, the program is designed to improve clinician knowledge, competence, and clinical performance, ultimately supporting more comprehensive, evidence-drivencare for patients with PsD and obesity.

Target Audience

US-based rheumatology prescribing clinicians (MDs, DOs, NPs, PAs)

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Describe the interplay between obesity and psoriatic disease (PsD) including inflammatory mechanisms, diseasesynergies, and real-world clinical burden.
  • Assess new and emerging targeted therapies for obesity based on mechanismsof action, key clinical trial data, indications, and compatibility with PsD treatment.
  • Identify appropriate PsD patients fornovel obesity therapies based on patient characteristics, comorbidities, contraindications, and treatment plans.
  • Incorporate patient-centered weight management strategies into psoriatic disease care plans to improve clinical outcomesand patient health.

Commercial Support

This activity is supported from an independent medical education grant from Lilly.

Course summary

Available credit: 
  • 1.50 AAPA Category 1 CME

    Physician Associates
    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 1.50 MOC_ABIM Medical Knowledge

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • 1.50 MOC_ABP Lifelong Learning & Self-Assessment

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.50 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

  • 1.50 AMA PRA Category 1 Credit™

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 ANCC Contact Hours

    Nurses
    Credit being awarded: 1.50 ANCC contact hours

  • 1.50 AMA PRA Category 1 Credit™ Non-MD

    Non-Physicians Seeking AMA Credit
    AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™.

Course opens: 
10/24/2026
Course expires: 
12/25/2026
Event starts: 
10/24/2026 - 1:00pm EDT
Event ends: 
10/24/2026 - 2:30pm EDT
Cost:
$0.00
Add to calendar: 
Rating: 
0
  • Obesity and Psoriatic Disease: Inflammatory overlap, Disease synergies, and Impact on Clinical and Patient Outcomes
  • GLP-1 and GIP Therapies: Mechanisms, Key Efficacy and Safety Data, Approved Indications, and Rheumatology-Focused Trials
  • Treatment Decision-Making: Evidence-Based Strategies for Integrating Weight Management, Pharmacologic Therapies, and Comorbidity Considerations in PsD Care
  • Case-Based Discussions: Personalized Care Plans to Optimize Outcomes for Patients with PsD and Obesity
Live-Virtual
United States

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.

Committee Member, Planner, Staff(s)

Dorothy Caputo, MA BSN RN

has no relevant financial relationships to disclose at this time.

Rebecca Lakofsky, BSN, RN

has no relevant financial relationships to disclose at this time.

Grace Wright, MD PhD FACR

has a financial relationship (Consultant) with AstraZeneca ;.
has a financial relationship (Consultant) with Bristol Myers Squibb;.
has a financial relationship (Consultant) with Eli Lilly;.
has a financial relationship (Consultant) with Fate Therapeutics ;.
has a financial relationship (Consultant) with Johnson & Johnson;.
has a financial relationship (Consultant) with Novartis;.
has a financial relationship (Advisor) with Pfizer;.
has a financial relationship (Consultant) with UCB;.
has a financial relationship (Consultant) with Abbvie;.
Course Director(s)

Grace Wright, MD PhD FACR

has a financial relationship (Consultant) with Eli Lilly;.
has a financial relationship (Consultant) with UCB;.
has a financial relationship (Advisor) with Pfizer;.
has a financial relationship (Consultant) with Novartis;.
has a financial relationship (Consultant) with Johnson & Johnson;.
has a financial relationship (Consultant) with Fate Therapeutics ;.
has a financial relationship (Consultant) with Bristol Myers Squibb;.
has a financial relationship (Consultant) with AstraZeneca ;.
has a financial relationship (Consultant) with Abbvie;.
Reviewer(s)

Dorothy Caputo, MA BSN RN

has no relevant financial relationships to disclose at this time.

Rebecca Lakofsky, BSN, RN

has no relevant financial relationships to disclose at this time.
Speaker, Instructor, Faculty(s)

Juliana Simonetti, Associated Professor, Director of Obesity Medicine, Department of Endocrinology, Metabolism and Diabetes

has a financial relationship (Consultant) with Rhythm pharmaceuticals;.
has a financial relationship (Consultant) with Eli Lilly ;.

 

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Association of Women in Rheumatology. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

This activity was planned by and for the healthcare team, and learners will receive 1.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

Available Credit

  • 1.50 AAPA Category 1 CME

    Physician Associates
    AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

  • 1.50 MOC_ABIM Medical Knowledge

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

  • 1.50 MOC_ABP Lifelong Learning & Self-Assessment

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.50 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

  • 1.50 AMA PRA Category 1 Credit™

    Physicians
    AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.50 ANCC Contact Hours

    Nurses
    Credit being awarded: 1.50 ANCC contact hours

  • 1.50 AMA PRA Category 1 Credit™ Non-MD

    Non-Physicians Seeking AMA Credit
    AKH Inc., Advancing Knowledge in Healthcare designates this Live Activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™.

Price

Cost:
$0.00
Please login or register to take this course.

Criteria for Success
To obtain credit, you must complete the activity evaluation and claim credit based on your attendance.  The Certificate of Completion is immediately available for download after submitting your evaluation.  It will remain in your profile transcript for future retrieval if needed.  It can be found under My Account > My Activities > Completed Activities.

If you have any questions, contact [email protected].